Folegatti PM, Pepin S, Tabar C, Fries K, et al. Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: results from a phase 3, immunobridging, open-label, non-randomised study. Lancet Infect Dis 2025 May 21:S1473-3099(25)00153.
PMID: 40412421